Publications by authors named "Maria R Motta"

Claim this Profile
T
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma.
Giulia Tolomelli, Katia Mancuso, Paola Tacchetti, Francesca Patriarca, Monica Galli, Maria Rosa Motta

Bone Marrow Transplant· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study.
Francesca Bonifazi, Elisa Dan, Myriam Labopin, Mariarosaria Sessa, Viviana Guadagnuolo, Maria Rosa Motta

Bone Marrow Transplant· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes.
Francesca Bonifazi, Jacopo Olivieri, Mariarosaria Sessa, Elisa Dan, Barbara Sinigaglia, Maria Rosa Motta

Biol Blood Marrow Transplant· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients.
Antonio Curti, Loredana Ruggeri, Sarah Parisi, Andrea Bontadini, Elisa Dan, Maria Rosa Motta

Clin Cancer Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation.
Francesca Bonifazi, Gianluca Storci, Giuseppe Bandini, Elena Marasco, Elisa Dan, Maria Rosa Motta

Haematologica· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collection of hematopoietic stem cells after previous radioimmunotherapy is feasible and does not impair engraftment after autologous stem cell transplantation in follicular lymphoma.
Enrico Derenzini, Vittorio Stefoni, Roberto Maglie, Beatrice Casadei, Cinzia Pellegrini, Maria Rosa Motta

Biol Blood Marrow Transplant· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hairy cell leukemia: allogeneic transplantation could be an optimal option in selected patients.
Pier Luigi Zinzani, Francesca Bonifazi, Cinzia Pellegrini, Beatrice Casadei, Lisa Argnani, Maria Rosa Motta

Clin Lymphoma Myeloma Leuk· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.
Antonio Curti, Loredana Ruggeri, Alessandra D'Addio, Andrea Bontadini, Elisa Dan, Maria Rosa Motta

Blood· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging.
Alessandro Isidori, Maria Rosa Motta, Monica Tani, Carolina Terragna, Pierluigi Zinzani

Biol Blood Marrow Transplant· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients.
Alessandro Isidori, Monica Tani, Francesca Bonifazi, Pierluigi Zinzani, Antonio Curti, Maria Rosa Motta

Haematologica· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience.
Pier Luigi Zinzani, Monica Tani, Annalisa Gabriele, Filippo Gherlinzoni, Antonello De Vivo, Maria Rosa Motta

Leuk Lymphoma· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic graft CD34(+) cell dose correlates with dendritic cell dose and clinical outcome, but not with dendritic cell reconstitution after transplant.
Benedetta Urbini, Mario Arpinati, Francesca Bonifazi, Gabriella Chirumbolo, Sadia Falcioni, Maria Rosa Motta

Exp Hematol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience.
Pier Luigi Zinzani, Monica Tani, Annalisa Gabriele, Filippo Gherlinzoni, Antonio de Vivo, Maria Rosa Motta

Haematologica· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of dendritic cells from CD14+ monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti-idiotype vaccination.
Maria R Motta, Samantha Castellani, Simonetta Rizzi, Antonio Curti, Francesco Gubinelli

Br J Haematol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis